TRANSGENOMIC INC | 2013 | FY | 3


Warrants to purchase an aggregate of 2,220,281 shares of common stock were outstanding at December 31, 2013.
 
Warrant Holder
 
Issue Year
 
Expiration
 
Underlying
Shares
 
Exercise
Price
Third Security Investors(1)
 
2010
 
December 2015
 
431,025
 
$6.96
Various Institutional Holders(2)
 
2012
 
February 2017
 
952,925
 
$12.96
Third Security Investors(2)
 
2012
 
February 2017
 
144,675
 
$12.96
Various Institutional Holders(3)
 
2013
 
January 2018
 
441,656
 
$9.00
Third Security Investors(3)
 
2013
 
January 2018
 
250,000
 
$9.00
 
 
 
 
 
 
2,220,281
 
 
(1)
This Warrant was issued in connection with the issuance of warrants to purchase shares of our Series A Preferred Stock to the Third Security Investors in December 2010. The number of underlying shares shown reflects the number of shares of common stock issuable upon conversion of the shares of Series A Preferred Stock for which this Warrant is currently exercisable.
(2)
These Warrants were issued in connection with the Private Placement completed in February 2012 and are classified as a liability in our financial statements. See Footnote 12 - Fair Value. These warrants also contain certain anti-dilution provisions that provide for an adjustment to the exercise price and number of shares issuable upon exercise of the warrant in the event that we engage in certain issuances of shares of our common stock at a price lower than the exercise price of the warrant.
(3)
These warrants were issued in connection with the offering, which was completed in January 2013.

us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock